| | | | | | | | | | | | | | | | |
2017 | | Quarter Ended March 31 | | | May 19, 2017 (date of initial capitalization) through June 30 | | | Quarter Ended September 30 | | | Quarter Ended December 31 | |
Total revenues | | $ | — | | | $ | — | | | $ | — | | | $ | 390 | |
Net loss | | $ | — | | | $ | — | | | $ | — | | | $ | (328 | ) |
Net loss attributable to stockholders | | $ | — | | | $ | — | | | $ | — | | | $ | (328 | ) |
Net loss per share | | $ | — | | | $ | — | | | $ | — | | | $ | (0.30 | ) |
Note 17. Subsequent Events
Market Development
On January 30, 2020, the World Health Organization declared the coronavirus(COVID-19) to be a public health emergency. As the result of rising infections in U.S., on March 13, 2020, the President of the United States declaredCOVID-19 a national emergency and many other world leaders have made similar declarations. This has created increased short term market volatility and adverse impacts on U.S. and world economies. Resulting business closures and individual restrictions may adversely impact the Company’s investments both in the U.S. and the International Affiliated Funds. At this time, the Company is unable to estimate the impact of this event on its investments and its operations.
Distributions
Our board of directors declared distributions on all outstanding shares of common stock as of the close of business on the record dates of October 31, 2019, November 30, 2019 and December 31, 2019. The Company paid these distributions amounting to $5.1 million on January 29, 2020.
On January 17, 2020, the Company’s board of directors amended the Company’s distribution policy to reflect that the Company intends to pay distributions monthly rather than quarterly going forward, subject to the discretion of the board of directors.
Our board of directors declared distributions amounting to $1.8 million each on all outstanding shares of common stock as of the close of business on the record date of January 31, 2020 and February 29, 2020 and the Company paid these distributions on February 27, 2020 and March 26, 2020, respectively.
Status of the Offering
On January 1, 2020 the Company sold approximately $10,087,060 of common stock (310,327 Class T shares, 260,338 Class S shares, 164,119 Class D shares & 209,963 Class I shares) at a purchase price of $10.64 for Class T, $10.64 for Class S, $10.73 for Class D, and $10.74 for Class I.
On February 1, 2020 the Company sold approximately $12,753,454 of common stock (3,087,278 Class T shares, 4,200,141 Class S shares, 1,174,421 Class D shares & 4,291,614 Class I shares) at a purchase price of $10.70 for Class T, $10.69 for Class S, $10.79 for Class D, and $10.81 for Class I.
On March 1, 2020 the Company sold approximately $19,468,472 of common stock (4,091,021 Class T shares, 5,674,518 Class S shares, 2,913,380 Class D shares & 6,789,554 Class I shares) at a purchase price of $10.70 for Class T, $10.66 for Class S, $10.79 for Class D, and $10.81 for Class I.
Other Items
On February 20, 2020, the Company funded an additional $6.4 million towards its $30.0 million commitment to APCF.
F-32